1.	Efficacy of Prophylactic Itraconazole in High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation Phase: Phase IV Type: Supportive care Status: Completed Age: 15 and under Sponsor: Other Protocol IDs: 2006-02-069, NCT00336531
2.	The Relationship of Defeverscence and Itraconazole Plasma Level Study Phase: Phase IV Type: Supportive care Status: Completed Age: 20 and over Sponsor: Pharmaceutical / Industry Protocol IDs: CR016597, ITR-KOR-5085, NCT01021683
3.	Efficacy of Itraconazole as Secondary Prophylaxis in Patients Undergoing Allogeneic Stem Cell Transplantation or Chemotherapy With Prior Invasive Fungal Infection Phase: Phase IV Type: Supportive care Status: Completed Age: 18 to 65 Sponsor: Other Protocol IDs: SpoIV-CHA-IIS-0802, ITRFUN4044, NCT01198236
4.	Prophylaxis Trial of Posaconazole Versus Standard Azole Therapy for Neutropenic Patients (Study P01899)(COMPLETED) Phase: Phase III Type: Supportive care Status: Completed Age: 13 and over Sponsor: Pharmaceutical / Industry Protocol IDs: P01899, NCT00044486
5.	A Pharmacokinetics Study of JK1211, Itraconazole Oral Solution, in Patients With Deep Mycosis and Those With Febrile Neutropenia Due to a Suspected Fungal Infection Phase: Phase III Type: Supportive care Status: Completed Age: 18 to 79 Sponsor: Pharmaceutical / Industry Protocol IDs: CR014299, JK1211-JPN-07, NCT00784368
6.	Itraconazole Compared With Fluconazole to Prevent Infections in Patients Undergoing Peripheral Stem Cell or Bone Marrow Transplantation Phase: Phase III Type: Supportive care Status: Completed Age: 13 and over Sponsor: NCI, Other Protocol IDs: 1322.00, FHCRC-1322.00, NCI-H99-0030, CDR0000067050, NCT00003883
7.	Phase I/II Study of PKC412 With or Without Itraconazole in Patients With Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes Phase: Phase II, Phase I Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI, Pharmaceutical / Industry Protocol IDs: MSKCC-02021, NOVARTIS-CPKC412A2104, NCI-G02-2107, UCLA-0305058-01, NCT00045578
8.	A Two-dose Level Clinical Trial of Itraconazole in Patients With Metastatic Prostate Cancer Who Have Had Disease Progression While on Hormonal Therapy Phase: Phase II Type: Treatment Status: Closed Age: 18 and over Sponsor: Other Protocol IDs: J0932, JHMI-IRB number: NA_00027099, NCT00887458
9.	Pilot Biomarker Trial to Evaluate the Efficacy of Itraconazole in Patients w/ Basal Cell Carcinomas Phase: Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Temporarily closed Age: 18 and over Sponsor: Other Protocol IDs: SKIN0004, SU-04162010-5722, NCT01108094
10.	An Open, Multicenter, Comparative Study of the Efficacy, Safety, and Tolerance of Fluconazole vs Itraconazole in the Treatment of Cancer Patients with Oropharyngeal Candidiasis (Summary Last Modified 09/92) Phase: No phase specified Type: Supportive care Status: Closed Age: 16 and over Sponsor: Protocol IDs: EORTC-19911
11.	Voriconazole Compared With Itraconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation Phase: No phase specified Type: Supportive care Status: Closed Age: 12 and over Sponsor: NCI, Other Protocol IDs: CDR0000355116, UCLA-0307071, NCT00079222
12.	A Pilot Trial of Itraconazole Pharmacokinetics in Patients With Metastatic Breast Cancer Phase: No phase specified Type: Treatment Status: Closed Age: 18 and over Sponsor: Other Protocol IDs: 0809-10; IUCRO-0239, NCT00798135
13.	Observational Study Investigating the Response Rate of Itraconazole Injection in Treating Immunocompromised Patients Phase: No phase specified Type: Supportive care Status: Completed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: CR015691, NCT01060462